EUVIMEDEUVIMED entdecken
Open Access

Rising Incidence of New Delhi Metallo-β-Lactamase–Producing Carbapenem-Resistant Enterobacterales, 10 US Sites, 2018–2023

Nadezhda Duffy iD, Davina Campbell, Rongxia Li iD, Joshua Brandenburg, Uzma Ansari, Alyssa G Kent iD, Joelle Nadle iD, Karlie Hoetzer, Helen Johnston iD, Jennifer Driscoll, Christopher Czaja, Meghan Maloney iD und 19 weitere

Open Forum Infectious Diseases · 01.08.2026 · 13 (8)

DOI: 10.1093/ofid/ofag477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 08.08.2026. Verfasst von Nadezhda Duffy und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CDC, Emerging Infections Program, Genomic Sequencing Laboratory of the Biotechnology Core Facility Branch.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We described the changing epidemiology of New Delhi metallo-β-lactamase (NDM)–producing carbapenem-resistant Enterobacterales (CRE) in 10 US sites conducting population-based CRE surveillance during 2018–2023.

Methods

A CRE case was defined as the first isolation of Escherichia coli, Enterobacter spp., or Klebsiella spp. resistant to ≥1 carbapenem from a sterile site or urine in a surveillance area resident within a 30-day period. Cases were classified as healthcare-associated or community-associated. Incidence rates were calculated using census data; trends were assessed using the Mann–Kendall test. Multivariable logistic regression was used to compare NDM- and Klebsiella pneumoniae carbapenemase-producing (KPC)–CRE. A subset of isolates underwent whole-genome sequencing.

Results

During 2018–2023, CRE incidence increased from 5.34 to 7.65 per 100 000 population (P = .02). NDM-CRE incidence increased from 0.07 to 0.66 per 100 000 population (P = .02); no significant trend was observed for KPC-CRE. Odds of being an NDM-CRE case were increased for community-associated versus healthcare-associated cases (adjusted odds ratio [aOR], 3.2; 95% CI, 1.98–5.17) and for cases aged 0–24 years versus ≥75 years (aOR, 3.99; 95% CI, 1.59–10.02). Genomic analysis showed diversity of sequence types among NDM- versus KPC-CRE.

Conclusions

Increases in CRE incidence appear to be driven by NDM-CRE, which are more likely than KPC-CRE to be community-associated. Continued surveillance is recommended to understand changes in epidemiology.

Schlagwörter

Stichwörter der Autor:innen

EnterobacteralesNew Delhi metallo-β-lactamase (NDM)-producing carbapenem-resistantchanging epidemiologyrising incidence

Autor:innen und Institutionen

  • Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • California Emerging Infections Program, Oakland, California, USA.
  • Colorado Department of Public Health and Environment, Denver, Colorado, USA.
  • Connecticut Emerging Infections Program, Connecticut Department of Public Health, Hartford, Connecticut, USA.
  • Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Georgia Emerging Infections Program, Atlanta, Georgia, USA.

ORCID-Profile: Nadezhda Duffy, Rongxia Li, Alyssa G Kent, Joelle Nadle, Helen Johnston, Meghan Maloney, Jesse T Jacob, Gillian Smith, Ghinwa Dumyati, Julia Tellerman, Kristina G Flores, Heather Hertzel, Amy S Gargis, Alice Y Guh

Förderung

  • CDC
  • Emerging Infections Program
  • Genomic Sequencing Laboratory of the Biotechnology Core Facility Branch

Zitieren

APA

Duffy, N., Campbell, D., Li, R., Brandenburg, J., Ansari, U., Kent, A. G., Nadle, J., Hoetzer, K., Johnston, H., Driscoll, J., Czaja, C., Maloney, M., Jacob, J. T., Smith, G., Vaeth, E., Wilson, L. E., Tourdot, L., Gross, A., Malley, S. O., …, & Guh, A. Y. (2026). Rising Incidence of New Delhi Metallo-β-Lactamase–Producing Carbapenem-Resistant Enterobacterales, 10 US Sites, 2018–2023. Open Forum Infectious Diseases, 13(8). https://doi.org/10.1093/ofid/ofag477

Vancouver

Duffy N, Campbell D, Li R, Brandenburg J, Ansari U, Kent AG, et al. Rising Incidence of New Delhi Metallo-β-Lactamase–Producing Carbapenem-Resistant Enterobacterales, 10 US Sites, 2018–2023. Open Forum Infectious Diseases. 2026;13(8). doi:10.1093/ofid/ofag477

BibTeX
@article{Duffy2026,
  author = {Duffy, Nadezhda and Campbell, Davina and Li, Rongxia and Brandenburg, Joshua and Ansari, Uzma and Kent, Alyssa G and Nadle, Joelle and Hoetzer, Karlie and Johnston, Helen and Driscoll, Jennifer and Czaja, Christopher and Maloney, Meghan and Jacob, Jesse T and Smith, Gillian and Vaeth, Elisabeth and Wilson, Lucy E and Tourdot, Laura and Gross, Annastasia and Malley, Sean O and Lynfield, Ruth and Dumyati, Ghinwa and Looi, Hsioa Che and Tellerman, Julia and Hoffman, Marisa R and Flores, Kristina G and Hertzel, Heather and Muleta, Daniel and Wilson, Christopher D and Karlsson, Maria and Gargis, Amy S and Guh, Alice Y},
  title = {Rising Incidence of New Delhi Metallo-β-Lactamase–Producing Carbapenem-Resistant Enterobacterales, 10 US Sites, 2018–2023},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {8},
  doi = {10.1093/ofid/ofag477}
}
Kostenlos starten →